Douglas G Adler

24PUBLICATIONS
6CO-AUTHORS
Molecular targetsOccupational epidemiologyFood engineeringToxicology (incl. clinical toxicology)Data models, storage and indexing
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|May 15, 2026
A comprehensive analysis of the adverse drug events of metastatic and unresectable gastrointestinal stromal tumor treatment options: avapritinib, imatinib, regorafenib, ripretinib, and sunitinib safety insights and implications.

|May 06, 2025
Dupilumab Use in Eosinophilic Esophagitis: Analysis of the FDA Adverse Event Reporting System Database.

Michael B Andrews, Hiba Khan, Douglas G Adler

|Apr 12, 2025
Comprehensive analysis of adverse drug reactions associated with teduglutide: post-marketing insights and safety implications.

Praneeth Kudaravalli, Michael B Andrews, Douglas G Adler

|Apr 08, 2025
Diarrhea-predominant irritable bowel syndrome treatment options eluxadoline, rifaximin, and alosetron: analysis of the FDA adverse event reporting system (FAERS) database.

Michael B Andrews, Douglas G Adler

|Jul 12, 2024
Gastroparesis treatment options metoclopramide and prucalopride: analysis of the FDA Adverse Event Reporting System (FAERS) database.

Michael B Andrews, Douglas G Adler

|Jun 28, 2024
Comparative Efficacy and Safety of Different Stent Types for Pancreatic Fluid Collections: A Systematic Review and Network Meta-Analysis.

Faisal Kamal, Muhammad Aziz, Wade Lee-Smith

Pageof 4

Frequent Collaborators

5 joint publications

Michael B Andrews

1 joint publications

Jeffrey S Bank

1 joint publications

Rahul Karna

1 joint publications

Manesh K Gangwani